For adults and adolescents with moderate-to-severe  plaque psoriasis , selective blockade of the interleukin-23 receptor with the targeted o...

For patients with celiac disease, treatment with a selective oral transglutaminase 2 inhibitor (ZED1227) attenuates gluten-induced duodenal ...